PIQ 6.90% 81.0¢ proteomics international laboratories ltd

Ann: AGM Chairman's Address and Investor Presentation, page-6

  1. 118 Posts.
    lightbulb Created with Sketch. 28
    Candour explained that the market didn't understand the gravity of what Promarker D will provide to the health industry of America, and it should become the standard of care for ALL diabetic patients, especially those who have advanced diabetic kidney disease as they may requite multiple tests per year, which is obviously profound for the company going forward. The other information, which all who have knowledge about Proteomics, was just reiterating the expected revenues. If they can sell 1000000 tests per year the expected revenue will be north of $60,000,000 Au, and they advised that each can do their own calculations of valuation. That should be the company's goal after the first year, I would think, with scope to greatly increase this with new markets opening up across Europe and Asia.
 
watchlist Created with Sketch. Add PIQ (ASX) to my watchlist
(20min delay)
Last
81.0¢
Change
-0.060(6.90%)
Mkt cap ! $106.0M
Open High Low Value Volume
86.0¢ 86.0¢ 79.5¢ $268.8K 328.3K

Buyers (Bids)

No. Vol. Price($)
2 21250 80.5¢
 

Sellers (Offers)

Price($) Vol. No.
81.0¢ 3091 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
81.5¢
  Change
-0.060 ( 6.25 %)
Open High Low Volume
86.0¢ 86.0¢ 80.0¢ 51140
Last updated 15.56pm 17/06/2024 ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.